Welcome to our dedicated page for Canopy Growth SEC filings (Ticker: CGC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Canopy Growth Corporation filings document the Canadian cannabis operator’s public-company reporting, including Form 8-K disclosures for quarterly results, Regulation FD releases, material agreements, shareholder voting outcomes and executive appointments. The company’s common shares are registered on Nasdaq under CGC, and filings describe capital-structure matters including senior secured debt financing and related guarantor arrangements.
Recent material-event filings also record the completed acquisition of MTL Cannabis Corp. and formal disclosures tied to operating results in Canada Cannabis and other business activities. Governance and risk-related filings cover proxy matters, voting mechanics, clinical or regulatory disclosure categories, and updates affecting the company’s cannabis brands, medical channels and Storz & Bickel vaporization devices.
Canopy Growth Corporation is asking shareholders to vote at its 2026 virtual annual general and special meeting on September 25, 2026 at 1:00 p.m. Toronto time. Five directors are nominated for election and PKF O’Connor Davies LLP is proposed for re-appointment as auditor.
Shareholders are also asked to approve a special share consolidation allowing the board to implement, by September 25, 2027, a consolidation ratio between 1‑for‑5 and 1‑for‑15 for both common and exchangeable shares, with fractional shares cancelled for no consideration. Additional proposals include ratifying an Advance Notice By‑Law for director nominations, renewing all unallocated entitlements under the Omnibus Incentive Plan, an advisory say‑on‑pay vote on named executive officer compensation, and an advisory vote on the frequency of future say‑on‑pay votes.
The proxy describes an executive bonus payout at 110.4% of target for fiscal 2026, driven by corporate objectives achieved at 195.1% of target despite Adjusted EBITDA at 24.2% of target and revenue at 61.5% of target. It also explains a prior non‑cash warrant‑classification accounting error that required restatement of earlier financial statements and led to a temporary management cease trade order that was lifted after filing the 2026 Form 10‑K.
Canopy Growth Corp director Joseph Bayern reported a small tax-related share sale. He disposed of 3,197 common shares on June 26, 2026 at $0.9237 per share, leaving him with 145,127 shares. A footnote explains the shares were withheld to cover taxes from recently vested RSUs, rather than a discretionary open-market sale.
Yanofsky Theresa reported open-market sale transactions in this Form 4 filing.
Canopy Growth Corp director Theresa Yanofsky disposed of 15,054 common shares on June 26, 2026 at $0.9237 per share. The filing explains these shares were granted as restricted stock units on June 17, 2026 and the disposition was tied to tax obligations arising from the RSU vesting, making this a compensation- and tax-related event rather than a purely discretionary trade. Following the transaction, Yanofsky directly holds 146,415 common shares.
Canopy Growth Corp director M. Shan Atkins reported a tax-related share sale linked to RSU vesting. On June 26, 2026, 3,197 common shares were disposed of at an average price of $0.9237 per share. According to the footnote, this disposition was associated with tax obligations arising from the vesting of restricted stock units granted on June 17, 2026.
After this transaction, Atkins directly holds 146,517 common shares. Because the filing describes the sale as tied to tax obligations on equity compensation, it reflects a routine administrative event rather than a discretionary open-market change in ownership.
Canopy Growth Corp director David Angelo Lazzarato reported a sale of 22,674 Common Shares at $0.9237 per share. According to the footnote, these shares were disposed of to cover tax obligations tied to the vesting of restricted stock units granted on June 17, 2026. After this transaction, he directly holds 211,859 Common Shares.
ATKINS M SHAN reported acquisition or exercise transactions in this Form 4 filing.
Canopy Growth Corp director ATKINS M SHAN received a stock award rather than buying shares on the market. On June 17, 2026, the director was granted 108,324 Common Shares in the form of restricted stock units at a price of $0.00 per share as compensation. These RSUs vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026 and March 29, 2027. After this grant, the director directly holds 149,714 Common Shares.
Lazzarato David Angelo reported acquisition or exercise transactions in this Form 4 filing.
Canopy Growth Corp director David Angelo Lazzarato received an equity award of 162,485 Common Shares on June 17, 2026. The award was granted at no cash cost to him as a compensation-related grant, not an open-market purchase.
The grant was made in the form of restricted stock units that vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026, and March 29, 2027. Following this grant, he directly holds 234,533 Common Shares.
BAYERN JOSEPH reported acquisition or exercise transactions in this Form 4 filing.
Canopy Growth Corp director Joseph Bayern received an equity award of 108,324 common shares on June 17, 2026. The shares were granted as restricted stock units, a form of stock-based compensation awarded at no cash cost to him.
These RSUs vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026, and March 29, 2027, aligning incentives over time. Following this grant, Bayern directly holds 148,324 common shares.
Yanofsky Theresa reported acquisition or exercise transactions in this Form 4 filing.
Canopy Growth Corp director Theresa Yanofsky received an equity award of 108,324 common shares on June 17, 2026. The shares were granted at no cash cost as restricted stock units (RSUs) and will vest in four equal installments on June 26, 2026, September 28, 2026, December 29, 2026 and March 29, 2027. After this grant, Yanofsky directly holds 161,469 common shares, reflecting her ongoing equity stake in the company.
Canopy Growth Corp officer Stewart Thomas Carlton reported a mix of equity award grants and a small share sale. He received 379,018 Common Shares as restricted stock units granted on June 17, 2026, which vest in three equal installments on June 15, 2027, June 15, 2028, and June 15, 2029. He was also granted 463,347 stock options exercisable at $0.99 per share, vesting annually over three years from the same grant date and expiring on June 17, 2032. On the same day, he disposed of 9,285 Common Shares at an average price of $0.9741, with the footnotes stating this disposition was tied to tax obligations from earlier RSU vesting. After these transactions, he directly held 616,398 Common Shares and 463,347 stock options.